Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
14 May 2021
Closing Date:
17 June 2021
Location(s):
PL229 Gliwicki (PL Poland/POLSKA)
Description:
Successive drug deliveries

The subject of this order is the successive supply of drugs for the National Institute of Im Oncology. Maria Skłodowsk-Curie, State Research Institute, Gliwice Branch.

The subject of the order is divided into two separate tasks, including:

— task 1 1 — Axicabtagene ciloleucel,

— Task 2 2 — Bexarotene.

1 — Axicabtagene ciloleucel

2. The description of the object of the contract and the conditions for the execution of the order are contained in

(a) Assortment and Price Specification — Annex No 2.1 to 2.2;

(b) the proposed provisions of the contract to be entered into the contents of the contract — Annex 4 to the SWZ.

2 — Bexarotene

2. The description of the object of the contract and the conditions for the execution of the order are contained in

(a) Assortment and Price Specification — Annex No 2.1 to 2.2;

(b) the proposed provisions of the contract to be entered into the contents of the contract — Annex 4 to the SWZ.

Download full details as .pdf
The Buyer:
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, Oddział w Gliwicach
CPV Code(s):
33600000 - Pharmaceutical products